Article

Intercast, Augen partner in NXT Rx sunlens distribution

Intercast Europe has made Augen Optics an authorized distributor of NXT Rx performance sunlenses. Intercast is a business of PPG Industries.

Key Points

NXT Rx sunlenses were developed to integrate fashion into the performance sport sunwear arena.

Pittsburgh-Intercast Europe has made Augen Optics an authorized distributor of NXT Rx performance sunlenses. Intercast is a business of PPG Industries.

NXT Rx sunlenses were developed to integrate fashion into the performance sport sunwear arena. The lenses combine Trivex lens material by PPG and Light Management Technology from Intercast. NXT Rx sunlenses provide 100% ultraviolet (UV) protection and are designed to produce high optical quality while offering ultra lightweight comfort, impact resistance, color uniformity, and advanced light filtration. The sunlenses are available in grey, brown, and green, as well as four photochromic dark-to-darker colors and two mirror-coated options.

"This partnership between Intercast and Augen is an excellent opportunity to provide consumers with a unique sunlens that can meet all the demands of an active, outdoor lifestyle," said Christine Camsuzou, PPG general manager, optical materials.

Augen has a wide range of products made with Trivex material, including Centurion Series progressive and single vision lenses available in Trivex material and Transitions lenses made with Trivex material.

"Adding NXT Rx sunlenses to our product mix expands our availability of exceptional lenses made with Trivex material while offering the best sun protection and performance," said John Potocny, Augen Optics senior vice president.

Compatible with all frame materials, NXT Rx sunlenses are highly resistant to solvents and can withstand rimless drilling without the risk of stress cracking.

Related Videos
Michael Rivers, MD, director of ophthalmology, Modernizing Medicine, shares what lingers on his mind in the field of ophthalmology at the end of the day.
Michael Rivers, MD, discusses how prior authorization policy affects cataract surgery
Michael X. Repka, MD, vice chair of clinical practice at Wilmer Eye Institute (Johns Hopkins University) speaks with Ophthalmology Times'®  Sheryl Stevenson
© 2024 MJH Life Sciences

All rights reserved.